Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Tiba Global Access is a private healthcare consultancy focused on commercialization and market access strategy for the biopharmaceutical industry. The firm appears to operate as an advisory business rather than a drug developer, with services centered on payer reimbursement, access, commercialization planning, and related policy strategy. Public references consistently identify Muna Bhanji as founder and president/principal of the company following her prior senior leadership career at Merck. Available evidence indicates the company is active and based in Ambler, Pennsylvania. No evidence was found of an internal therapeutic pipeline or proprietary clinical-stage assets.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Tiba Global Access.